Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Antiplatelet and Anticoagulation Therapies

March 27, 2017 — Using genetic testing to help personalize warfarin therapy given to patients undergoing elective ...

Home March 27, 2017
Home
News | Information Technology

March 24, 2017 — Safe implementation of new technologies and therapies accompany classic patient safety challenges on ...

Home March 24, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

March 23, 2017 — Bleeding complications did not increase for patients with acute coronary syndrome treated with ...

Home March 23, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

March 23, 2017 — In patients at elevated risk for a recurrence of potentially life- threatening blood clots, a low dose ...

Home March 23, 2017
Home
News | Pharmaceuticals

March 22, 2017 — In a clinical program that was terminated early, the experimental PCSK9 inhibitor bococizumab, when ...

Home March 22, 2017
Home
RESOLVE study, RESOLVE trial, subclinical leaflet thrombosis
Feature | Heart Valve Technology

March 21, 2017 — About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood clots ...

Home March 21, 2017
Home
Evolocumab, Repatha, LDL, ACC late breaker, best LDL lowering drug
Feature | Pharmaceuticals

March 20, 2017 — The most important late-breaking pharmaceutical trial at the 2017 America College of Cardiology annual ...

Home March 20, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

March 14, 2017 — More than 80 percent of stroke patients with a history of atrial fibrillation either received not ...

Home March 14, 2017
Home
Technology | Stents

March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc. first-in-class Cobra PzF ...

Home March 02, 2017
Home
News | Heart Failure

February 22, 2017 — The American College of Cardiology (ACC), Haymarket Medical Education (HME) and myCME have joined ...

Home February 22, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

February 9, 2017 — Janssen Research & Development LLC (Janssen) announced that the Phase 3 COMPASS trial is stopping ...

Home February 09, 2017
Home
News | Pharmaceuticals

February 7, 2017 — GE Healthcare’s Life Sciences business announced in January that it acquired Rapidscan Pharma ...

Home February 07, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

January 17, 2017 — Warfarin is a commonly prescribed blood thinner used to prevent harmful blood clots. However, the ...

Home January 17, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

January 11, 2017 — For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of ...

Home January 11, 2017
Home
Feature | Point of Care Testing | Ravi Chawat

Point of care testing devices are gaining widespread approval for prompt medical diagnoses, especially in cardiology and ...

Home December 30, 2016
Home
Subscribe Now